A case of endocarditis caused by the yeast Pichia fabianii with biofilm production and developed in vitro resistance to azoles in the course of antifungal treatment

Medical Mycology

Volumn 46, Issue 6, 2008, Pages 601-605

  Hamal, Petr ^a   Ostransky, Jiri ^b   Dendis, Milos ^c   Horvath, Radek ^c   Ruzicka, Filip ^d   Buchta, Vladimir ^e   Vejsova, Marcela ^e   Sauer, Pavel ^a   Hejnar, Petr ^a   Raclavsky, Vladislav ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^c Geneproof Inc   (Czech Republic)

^d MASARYK UNIVERSITY   (Czech Republic)

^e CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Antifungal resistance; Biofilm production; ITS sequencing; Pichia fabianii; Systemic mycoses

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CEFOTAXIME; FLUCONAZOLE; GENTAMICIN; INTERNAL TRANSCRIBED SPACER 2; PYRROLE DERIVATIVE; RIBOSOME RNA; VORICONAZOLE;

ADULT; ANTIFUNGAL RESISTANCE; AORTA GRAFT; ARTICLE; BACTERIAL INFECTION; BIOFILM; CANDIDIASIS; CASE REPORT; CEREBROVASCULAR ACCIDENT; FUNGAL DETECTION; FUNGAL ENDOCARDITIS; FUNGAL STRAIN; FUNGUS ISOLATION; HEART SURGERY; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PICHIA; PICHIA FABIANII; PREOPERATIVE PERIOD; RETREATMENT; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; URINARY TRACT INFECTION;

ADULT; ANTIFUNGAL AGENTS; AZOLES; BIOFILMS; DRUG RESISTANCE, FUNGAL; ENDOCARDITIS; HUMANS; MALE; MYCOSES; PICHIA;

PICHIA ANOMALA; PICHIA FABIANII;

EID: 51749105707     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802078180     Document Type: Article

References (21)

1. Horstkotte, D., Follath, F. Gutschik, E. et al. (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J, 25, pp. 267-276.
2. Baddour, LM, Wilson, WR Bayer, AS et al. (2005) Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation, 111, p. e394.
3. Lopez-Ciudad, V., Castro-Orjales, MJ Leon, C. et al. (2006) Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole. BMC Infect Dis, 6, p. 73.
4. Rajendram, R., Alp, NJ, Mitchell, AR, Bowler, IC and Forfar, JC. (2005) Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement. Clin Infect Dis, 40, p. e72.
5. Nohinek, B., Zee-Cheng, CS, Barnes, WG, Dall, L. and Gibbs, HR. (1987) Infective endocarditis of a bicuspid aortic valve caused by Hansenula anomala. Am J Med, 82, pp. 165-168.
6. Buchaille, L., Freydiere, AM, Guinet, R. and Gille, Y. (1998) Evaluation of six commercial systems for identification of medically important yeasts. Eur J Clin Microbiol Infect Dis, 17, pp. 479-488.
7. (2000) Yeasts: Characteristics and Identification, Cambridge University Press, Cambridge
8. (1998) The Yeasts: A Taxonomic Study, pp. 273-352. Elsevier, Amsterdam
9. Naumov, GI, Naumova, ES and Schnurer, J. (2001) Genetic characterization of the nonconventional yeast Hansenula anomala. Res Microbiol, 152, pp. 551-562.
10. Shin, JH, Kee, SJ Shin, MG et al. (2002) Biofilm production by isolates of Candida species recovered from nonneutropenic patients: Comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol, 40, pp. 1244-1248.
11. Dooley, DP, Beckius, ML, McAllister, CK and Jeffery, BS. (1990) Prostatitis caused by Hansenula fabianii. J Infect Dis, 161, pp. 1040-1041.
12. Bhally, HS, Jain, S. Shields, C. et al. (2006) Infection in a neonate caused by Pichia fabianii: Importance of molecular identification. Med Mycol, 44, pp. 185-187.
13. Valenza, G., Valenza, R., Brederlau, J., Frosch, M. and Kurzai, O. (2006) Identification of Candida fabianii as a cause of lethal septicaemia. Mycoses, 49, pp. 331-334.
14. Thuler, LC, Faivichenco, S. Velasco, E. et al. (1997) Fungaemia caused by Hansenula anomala-an outbreak in a cancer hospital. Mycoses, 40, pp. 193-196.
15. Bakir, M., Cerikcioglu, N. Tirtir, A. et al. (2004) Pichia anomala fungaemia in immunocompromised children. Mycoses, 47, pp. 231-235.
16. Hirasaki, S., Ijichi, T. Fujita, N. et al. (1992) Fungemia caused by Hansenula anomala: Successful treatment with fluconazole. Intern Med, 31, pp. 622-624.
17. Hall, L., Wohlfiel, S. and Roberts, GD. (2003) Experience with the MicroSeq D2 large-subunit ribosomal DNA sequencing kit for identification of commonly encountered, clinically important yeast species. J Clin Microbiol, 41, pp. 5099-5102.
18. National Committee for Clinical Laboratory Standards (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard-M27A2. National Committee for Clinical Laboratory Standards.Wayne, PA
19. Pfaller, MA, Diekema, DJ Rex, JH et al. (2006) Correlation of MIC with outcome for Candida species tested against voriconazole: Analysis and proposal for interpretive breakpoints. J Clin Microbiol, 44, pp. 819-826.
20. Panackal, AA, Gribskov, JL Staab, JF et al. (2006) Clinical significance of azole antifungal drug cross-resistance in Candida glabrata. J Clin Microbiol, 44, pp. 1740-1743.
21. Magill, SS, Shields, C., Sears, CL, Choti, M. and Merz, WG. (2006) Triazole cross-resistance among Candida spp.: Case report, occurrence among bloodstream isolates, and implications for antifungal therapy. J Clin Microbiol, 44, pp. 529-535.